, May 21, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
Company to Present and Host 1x1 Investor Meetings on Thursday, June 4th, 2026
AUSTIN, Texas, May 21th, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and, together with Ken Mobeck, Chief Financial Officer, will host 1x1 investor meetings at the upcoming Jefferies 2026 Global Healthcare Conference in New York.
Date: Thursday, June 4th
Time: 2:00-2:30 PM ET
Format: Presentation and 1x1 investor meetings
Webcast: https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/mNTgvmem3UJgTk2XzExVDK
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.
Investor Contact
Louisa Smith
Gilmartin Group
Investor.relations@focalone.com
